Alvotech Signs Supply and Commercialization Agreements with Sandoz for Biosimilars in Canada, Australia, and New Zealand

Alvotech has entered supply and commercialization agreements with Sandoz for multiple biosimilar candidates in Canada and Australia/New Zealand. The agreements cover ophthalmology, immunology, and gastroenterology biosimilars, with Sandoz responsible for regulatory submissions, commercialization, and distribution. Alvotech will retain development, global clinical activities, and manufacturing responsibilities.